Epidemiology of Klebsiella Pneumoniae in China
NCT03598543 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-07-26
Summary
Klebsiella pneumoniae is one of the most common pathogens causing both community-onset and nosocomial infection. More worse, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics,outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.
Conditions
- Klebsiella Pneumoniae Infection
Interventions
- OTHER
-
no intervention
no intervention, this is an obervational study.
Sponsors & Collaborators
-
Sir Run Run Shaw Hospital
lead OTHER
Principal Investigators
-
Yun-song Yu, MD · Zhejiang University
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-01
- Primary Completion
- 2018-10-31
- Completion
- 2018-12-31
Countries
- China
Study Locations
More Related Trials
-
Incidence and Risk Factors for Developing Infections in Patients Colonized by CP-KPC
NCT05492539 ·Status: UNKNOWN
-
Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital
NCT05862402 ·Status: UNKNOWN ·Phase: PHASE4
-
Epidemiological, Clinical, Microbiological and Outcome Description of Patients With Klebsiella sp Meningitis
NCT03967210 ·Status: COMPLETED
-
Risk Factors for Linezolid Resistance in Staphylococcus Aureus
NCT00519025 ·Status: COMPLETED
-
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection
NCT06051513 ·Status: RECRUITING ·Phase: NA
-
Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species
NCT00518661 ·Status: COMPLETED
-
Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infections
NCT03094494 ·Status: COMPLETED
-
Population Pharmacokinetics of Commonly Used Antimicrobial Agents in Children of Bacterial Meningitis With Augmented Renal Clearance
NCT04771884 ·Status: RECRUITING
-
Microbiology Studies of Acute Head and Neck Infections
NCT05874908 ·Status: ENROLLING_BY_INVITATION
-
Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin
NCT02443064 ·Status: UNKNOWN ·Phase: PHASE4
-
Turkish Prospective Cohort Study on Carbapenem Resistant Klebsiella Pneumonia Bacteremia
NCT03597841 ·Status: COMPLETED
-
Fecal Microbiota Transplantation in Patients With Multiple Drug Resistant Klebsiella Pneumoniae Pneumonia
NCT06641778 ·Status: RECRUITING ·Phase: NA
-
Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections
NCT04785924 ·Status: WITHDRAWN ·Phase: PHASE4
-
Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae
NCT03767283 ·Status: UNKNOWN
-
Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
NCT02482961 ·Status: COMPLETED
-
Clinical and Microbiological Outcomes of Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
NCT01041716 ·Status: COMPLETED
-
Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy
NCT01352936 ·Status: UNKNOWN
-
Individualized Precision Therapy With Ceftobiprole Guided by PK/PD in Geriatric Populations
NCT07127185 ·Status: NOT_YET_RECRUITING
-
Detection of Clindamycin Resistance Antibiotic Genes Among Staphylococcus Isolates by Using Real Time PCR
NCT04933019 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection
NCT05586815 ·Status: UNKNOWN ·Phase: PHASE4
-
PREdiction of CEphalosporinase Producing Enterobacteria During Ventilator-associated Pneumonia for Therapeutic Stewardship
NCT05486130 ·Status: UNKNOWN
-
Vancomycin in the Target Site Treatment of Intracranial Infection
NCT03585426 ·Status: UNKNOWN ·Phase: PHASE4
-
Real-world Daptomycin Use in Chinese ICUs
NCT03588637 ·Status: COMPLETED
-
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
NCT01597973 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections
NCT01314053 ·Status: UNKNOWN